跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Diprivan - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Diprivan
Approved
STANDARD
Diprivan
Corden Pharma S.P.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0502239ffdd0a896
Company
Corden Pharma S.P.A.
Type
Standard
Approval Details
Approval Id
0502239ffdd0a896
Drug Approval Philippines Name
Diprivan
Product Name
Diprivan
Registration Number
DR-XY28593
Brand Name
Diprivan
Generic Name
Propofol
Dosage Form
Emulsion For Intravenous Injection
Dosage Strength
10 mg/mL
Manufacturer
Corden Pharma S.P.A.
Importer
Aspen Philippines, Inc.
Company Detail Path
/organization/corden-pharma-spa
Issuance Date
23 February 2023
Expiry Date
29 April 2028
Pharmacologic Category
General Anesthetic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0502239ffdd0a896
Type
Standard
Back to Philippines FDA Approvals